[Cobalt radioisotope teletherapy of patients with metastases to the brain].
The results are presented of palliative telecobaltotherapy in patients with metastases to the brain. The patients received a dose of 30 Gy in 10 fractions during 2 weeks. Clinical improvement was achieved in 28 out of 33 treated patients (85%). The survival time after the completion of radiotherapy was from 1 to 15 months, mean 5 months.
Karnicka-Młodkowska
H
H
Kliniki Radioterapii AM w Gdańsku.
Jassem
J
J
Dziewulska-Bokiniec
A
A
D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D001943:Breast Neoplasms; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D003138:Common Bile Duct Neoplasms; D005260:Female; D006801:Humans; D008175:Lung Neoplasms; D008297:Male; D008875:Middle Aged; D011867:Radioisotope Teletherapy
D003037:Cobalt Radioisotopes
Telekobaltoterapia chorych z przerzutami do mozgu.